ASCO Congratulates Seema Verma on Confirmation as CMS Administrator

Statement by ASCO President Daniel F. Hayes, MD, FACP, FASCO
For immediate release
March 13, 2017

Contact

Melissa Lee
571-483-1661

“The American Society of Clinical Oncology (ASCO) congratulates Seema Verma for her confirmation as Administrator of the Centers for Medicare & Medicaid Services (CMS). Administrator Verma is now in a key position to lead the agency during the next phase of healthcare reform in the United States, and to help ensure that millions of Medicare and Medicaid beneficiaries with cancer have access to high-quality oncology care.

“ASCO has previously called for Medicaid reform to ensure access to life-saving screening, treatment and prevention services for low-income Americans with cancer. We are, therefore, hopeful that Administrator Verma’s experience designing Indiana’s Medicaid expansion program will now benefit all Medicare and Medicaid beneficiaries on the national stage.  

“We are looking forward to working with Administrator Verma and CMS to improve the care received by Medicare and Medicaid beneficiaries with cancer and to ensure access to affordable and necessary healthcare coverage for all Americans regardless of income or health status.”

# # #

About ASCO: 

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube. Visit ascoaction.asco.org for the latest cancer policy developments. For an overview of current policy issues, read ASCO’s cancer policy issue briefs.